Riluzole, solid

Code: R116-500MG D2-231

Biochem/physiol Actions

Glutamate release inhibitor; anticonvulsant

Features and Benefits

This compound is featured on the Potassium Channels pag...


read more

Your Price
£799.00 500MG
£958.80 inc. VAT
REQUEST

Biochem/physiol Actions

Glutamate release inhibitor; anticonvulsant

Features and Benefits

This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

250, 500 mg in glass bottle

25 mg in poly bottle

formsolid
Gene Informationhuman ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335)rat ... Scnn1g(24768)
InChI keyFTALBRSUTCGOEG-UHFFFAOYSA-N
InChI1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)
originatorSanofi Aventis
Quality Level100
SMILES stringNc1nc2ccc(OC(F)(F)F)cc2s1
Code
Description
Unit Size
List Price
Qty
R116-25MG
Riluzole, solid

Unit:25MG
List Price: £103.00
Source:List Price
ADD
R116-250MG
Riluzole, solid

Unit:250MG
List Price: £623.00
Source:List Price
ADD
Cas Number1744-22-5
Hazard Class6.1
Un Number2811
Pack Group3
This product has met the following criteria: